Celgene Alpine Investment Co., LLC is 10% Owner at AGIOS PHARMACEUTICALS, INC. (AGIO). They have made 2 open-market trades across 1 company since 2018, most recently 2019-11-12.
CIK 0001581774
2 open-market purchases totalling $69.5M since 2018, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| AGIO | 1,777,824 | $55.8M |
Shares reported on the most recent Form 4, priced at the 2019-11-14 close.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.